MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
2.020
-0.130 (-6.05%)
At close: Jul 18, 2025, 4:00 PM
2.050
+0.030 (1.47%)
After-hours: Jul 18, 2025, 7:42 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Cell Therapy
22.83M
Log In
Log In
Log In
Log In
Upgrade
Cell Therapy Growth
-25.26%
Log In
Log In
Log In
Log In
Upgrade
Program-related
11.47M
Log In
Log In
Log In
Log In
Upgrade
Program-related Growth
148.38%
Log In
Log In
Log In
Log In
Upgrade
Drug Discovery
6.99M
Log In
Log In
Log In
Log In
Upgrade
Drug Discovery Growth
-23.14%
Log In
Log In
Log In
Log In
Upgrade
Leased Elements
-
Log In
Log In
Log In
Log In
Upgrade
Leased Elements Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
41.29M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-6.72%
Log In
Log In
Log In
Log In
Upgrade